Etoricoxib showed rapid onset of efficacy and sustained duration of therapy over the 24-hour dosing interval in patients with osteoarthritis (OA) of the knee or hip

Authors
Category Primary study
JournalAnn Rheum Dis
Year 2002
This article has no abstract
Epistemonikos ID: 0aefcba84f2f5935806d76227d1e41e69292b280
First added on: Mar 25, 2025